Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 09-2014 | |
| Operating Expenses | 0 | 6,410 |
| Operating Income | N/A | -6,410 |
| Other Income | 0 | 1,940 |
| Pre-tax Income | 0 | -4,470 |
| Net Income Continuous | -1,855 | -4,180 |
| Net Income | $-1,855 | $-4,180 |
| EPS Basic Total Ops | -0.30 | -0.53 |
| EPS Basic Continuous Ops | -0.30 | -0.53 |
| EPS Diluted Total Ops | -0.30 | -0.53 |
| EPS Diluted Continuous Ops | -0.30 | -0.53 |
| EBITDA(a) | $80 | $-6,410 |